Last reviewed · How we verify

NCT03300128: IY-ASD

Incredible Years Program for Parents of Children with Autism

Terminated NA Last updated 26 November 2024
What this trial tests

NA trial testing Incredible Years - ASD in Autism Spectrum Disorder in 27 participants. Terminated before completion.

Timeline
1 June 2017
Primary endpoint
31 May 2018
10 December 2018

Quick facts

Lead sponsorUniversity of Maryland, Baltimore
PhaseNA
StatusTerminated
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment27
Start date1 June 2017
Primary completion31 May 2018
Estimated completion10 December 2018
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

University of Maryland, Baltimore

Who can join

18 and older, any sex, with Autism Spectrum Disorder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Early intervention for children with Autism Spectrum Disorder (ASD), particularly with parent involvement, is beneficial for both children and their families. However, few interventions have been rigorously tested which explicitly address parent and family outcomes. This study will test the effectiveness of "The Incredible Years Parent Program for Autism Spectrum and Language Delays" (IY-ASD) program for parents of children with ASD ages 2-8 in a community-based setting, compared to a parent support program, "Circle of Parents." The investigators will assess parent stress, caregiver coping, child behavior, parenting practices of participants. In addition, the investigators will report on participants' satisfaction with IY-ASD, through parent interviews and satisfaction surveys.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Autism Spectrum Disorder

Currently open trials in the same condition.

Other University of Maryland, Baltimore trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03300128.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing